Comparison
13q Partial Monosomy Syndrome C0265451 vs 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Clinical comparison between 13q Partial Monosomy Syndrome and 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial for differential diagnosis and treatment planning.
13q Partial Monosomy Syndrome C0265451
A rare genetic condition involving deletion of material from chromosome 13. It can lead to developmental delays, growth concerns, and various physical features. Treatment involves supportive care addressing each individual's specific challenges.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
A partial form of enzyme deficiency affecting hormone production. Symptoms vary but may include hormonal imbalances and elevated blood pressure. Treatment usually involves hormone replacement and regular medical follow-up.
6 comparison axes
Onset
13q Partial Monosomy Syndrome C0265451
0-null
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Variable
Onset patterns differ
Severity
13q Partial Monosomy Syndrome C0265451
severe
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
severe
Different severity levels
Chronic
13q Partial Monosomy Syndrome C0265451
Chronic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
Chronic
Differing course
Communicable
13q Partial Monosomy Syndrome C0265451
No
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
No
Different transmission
Body System
13q Partial Monosomy Syndrome C0265451
congenital
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
endocrine
Same/different system
Category
13q Partial Monosomy Syndrome C0265451
genetic
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
endocrine
Different category
Bottom line
13q-partial-monosomy-syndrome-C0265451 and 17-alpha-hydroxylase-17-20-lyase-deficiency-combined-partial-C4017190 differ in etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 13q Partial Monosomy Syndrome C0265451 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 | Discriminating power |
|---|---|---|---|
| Developmental pattern | Developmental delay and congenital features may be prominent. | Hormone imbalance is more characteristic than a chromosomal phenotype. | High |
| Blood pressure | Hypertension is not a defining feature from the supplied data. | Elevated blood pressure may occur, but not in every person. | Moderate |
| Growth and physical features | Growth concerns and variable physical features may be present. | Physical findings, if any, relate mainly to hormonal effects. | Moderate |
When to favor each condition
Choose 13q Partial Monosomy Syndrome C0265451 when
Congenital anomalies with developmental delay
A chromosomal evaluation is more relevant than an endocrine enzyme diagnosis.
High
Known or suspected chromosome 13 deletion
Genetic confirmation supports the left condition rather than a hormone disorder.
High
Multisystem congenital presentation
Supportive care is guided by individual findings, not hormone replacement alone.
Moderate
Choose 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 when
Unexplained hypertension with hormonal imbalance
This pattern fits the supplied endocrine description better than a chromosomal deletion.
Moderate
Abnormal steroid profile suggesting CYP17A1 pathway dysfunction
Specialist endocrine and genetic interpretation is required; a result is not itself a diagnosis.
Moderate
Need for hormone replacement follow-up
Management described for the right condition centers on hormones and monitoring.
Moderate
How key tests differ
| Test | 13q Partial Monosomy Syndrome C0265451 | 17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May identify partial loss of chromosome 13 material. | Not expected to establish this enzyme deficiency. | A chromosomal finding supports the left diagnosis only after laboratory confirmation. |
| Steroid hormone profile | No characteristic pattern is established by the supplied data. | May suggest impaired cortisol and sex-steroid production with mineralocorticoid effects. | Abnormal results require clinician correlation and are not definitive alone. |
| Blood pressure and electrolyte assessment | No specific abnormality is established here. | Hypertension or electrolyte changes may be found in some patients. | Findings are supportive only and need endocrine interpretation. |
Prognosis comparison
13q Partial Monosomy Syndrome C0265451
- Outcome
- Chronic course with variable developmental and medical needs; exact outcomes are not established here.
- Factors
- Deletion extent, associated anomalies, and available supportive services may influence needs.
17 Alpha Hydroxylase 17 20 Lyase Deficiency Combined Partial C4017190
- Outcome
- Chronic endocrine condition; outlook depends on hormonal control and blood-pressure management.
- Factors
- Degree of enzyme deficiency, treatment adherence, and monitoring may matter.
Time frame: Lifelong follow-up is generally expected, but individual course varies.
Neither condition is communicable; prognosis should be interpreted by the treating clinician.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental challenges | Delays and learning or functional needs may require long-term support. Not a defining complication in the supplied description. Individual assessment determines services; outcomes are not uniform. |
| Hormonal deficiency | Not established as a core feature. Partial hormone production defects may need replacement and monitoring. Doses and targets must be individualized by a clinician. |
| Cardiovascular effects | No specific cardiovascular course is established here. Elevated blood pressure may contribute to risk if present. Blood pressure findings require clinical evaluation rather than assumption. |
Patient education highlights
- HighDifferent causes
One condition involves missing chromosome 13 material; the other is a partial enzyme deficiency affecting hormones.
- HighIndividual care
Features vary. Care plans should address confirmed needs rather than a fixed symptom list.
- MediumFollow-up
Genetic or endocrine specialists should interpret tests and coordinate supportive or hormone-related care.